From: Increasing Hepatitis C treatment uptake among HIV-infected patients using an HIV primary care model
Clinic model | Hepatology | HIV primary care | P value |
---|---|---|---|
(n = 163) | (n = 196) | ||
Median age - years (range) | 45(26–73) | 48(19–75) | 0.02a |
Sex: Male (%) | 137(84) | 165(84) | 0.97b |
Race | |||
White | 115 | 138 | 0.20c |
Black | 39 | 50 | |
Asian | 0 | 3 | |
Other/unknown | 9 | 5 | |
Ethnicity | |||
Hispanic | 35 | 26 | 0.03c |
Not-Hispanic | 121 | 167 | |
Unknown | 7 | 3 | |
HIV risk factors | |||
Gay/bisexual | 79 | 78 | 0.003c |
Heterosexual | 24 | 46 | |
Intravenous drug use | 3 | 8 | |
Hemophilia | 8 | 5 | |
combination | 25 | 47 | |
Other/unknown | 24 | 12 | |
Median CD4+ cell count - cells/mm3 (range)1 | 372 (29–1179) | 431 (38–1612) | 0.05a |
Median HIV load - log10 copies/mL (range) | 2.6 (2.6–5.8) | 2.6 (2.6–6.6) | 0.12a |
Number on HAART therapy - % | 132 (81) | 172 (88) | 0.08b |
Hepatitis C genotype2 | |||
Genotype 1,4 | 125 | 158 | 0.68c |
Genotype 2,3 | 31 | 35 | |
Median HCV load - log10 copies/mL (range)3 | 6.29 (1.9–8.4) | 6.43 (2.2–8.4) | 0.43a |
Liver biopsy scores 4 | |||
F0-2 | 39 | 42 | 0.95c |
F3,4 | 37 | 39 | |
Any neuropsychiatry history – % | 100 (61%) | 119 (61%) | 0.85b |
On any psychiatry medications - % | 75 (46%) | 88 (45%) | 0.83b |
Drugs or alcohol use within 3months of HCV treatment consideration | |||
No | 71 | 115 | 0.0001c |
yes | 45 | 72 | |
unknown | 47 | 9 | |
Median hemoglobin levels - g/dL (range) | 14.7 (9–18.7) | 14.3 (7.7–17.6) | 0.13a |
Median platelet count -1000/mm3 (range) | 184 (44–531) | 208 (41–548) | 0.004a |
Median ALT - U/L (range) | 68 (20–980) | 57 (12–1280) | 0.51a |
Median INR (range) | 1.1 (0.9–2.3) | 1.0 (0.9–2.6) | 0.05a |